Skip to content

Opening book details…

Can I read Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation on EtoBox?

Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation by E. Yagmur; C. Trautwein; M.P.G. Leers; A.M. Gressner; F. Tacke is a Medicine article available to read on EtoBox.

What is Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation about?

## Objectives: During apoptosis, intermediate filament protein cytokeratin 18 (ck18) is cleaved by caspases at asp396 which can be specifically detected by the monoclonal antibody m30 (m30-antigen). ## Design and methods: M30-antigen serum levels were analyzed in 76 chronic liver diseases (cld) patients and 62 healthy controls. ## Results: M30-antigen levels were significantly elevated in cld patients (median 296.3 u/l) compared with healthy controls (median 153.5 u/l, p<0.001) and increased with disease severity (child-pugh or meld score). m30-antigen correlated with aminotransferase activities and parameters indicating cholestasis such as bile acids. highest serum m30-antigen was associated with histologically confirmed severe intrahepatic cholestasis (median 599.1 u/l) or biliary duct inflammation (median 648.0 u/l). furthermore, in contrast to patients with liver cirrhosis, presence of hepatocellular carcinoma was associated with elevated m30-antigen in patients without cirrhosis. ## Conclusion: Serum m30-antigen levels are elevated in cld and correlate with hepatic inflammation as well as cholangitis and cholestasis.

Who reads Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation?

It is typically read by researchers, students, and practitioners in Medicine.

Author
E. Yagmur; C. Trautwein; M.P.G. Leers; A.M. Gressner; F. Tacke
Publisher
Elsevier Science; Elsevier ; Elsevier BV (ISSN 0009-9120)
Published
2007
Language
EN
Field
Medicine (Health Sciences)

More by E. Yagmur; C. Trautwein; M.P.G. Leers; A.M. Gressner; F. Tacke

Browse all works by E. Yagmur; C. Trautwein; M.P.G. Leers; A.M. Gressner; F. Tacke